Glycopyrrolate Injection
Product Images NDC 71872-7181

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 71872-7181). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71872-7181-1.pdp (71872 7181 1)

71872-7181-1.pdp (71872 7181 1)
This is a description of Glycopyrrolate Injection, USP, 0.2 mg/mL 1 mL Single-Dose Vial. The injection contains benzyl alcohol as a preservative and is not for use in newborns. It is used intramuscularly or intravenously and usual dosage can be found in the package insert. The injection is stored at a temperature of 20° to 25°C and the manufacturer is Sandoz Inc., a product of Italy. The item has been repackaged by Medical Purchasing Solutions and distributed from Scotisdale, AZ 85260.*
FDA Label Image

Chemical-structure (Glycopyrrolate Injection 01)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.